In summary, a comprehensive analysis of the above-mentioned databases shows that LMAN2 expression is affected by its m6A methylation status and that LMAN2 alters the DNA damage repair pathway, thereby affecting the prognosis of HER2-positive breast cancer patients. The gene discussed is LMAN2; the disease is breast carcinoma.